Locations:
Search IconSearch

Adopting New Technologies for Multiple Sclerosis Rehabilitation (Podcast)

A veteran clinician shares insights on the care-enhancing qualities of tech

“There’s a potentially large place for technology in multiple sclerosis [MS] rehabilitation, but we have to understand that it’s in partnership with the people who have MS and their families, who are the ones to decide how best it can help them.” That’s a takeaway shared by Francois Bethoux, MD, Director of Rehabilitation Services in Cleveland Clinic’s Mellen Center for Multiple Sclerosis, in the newest episode of Cleveland Clinic’s peer-to-peer Neuro Pathways podcast.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

In the podcast, Dr. Bethoux — who is also Chair of Cleveland Clinic’s Department of Physical Medicine and Rehabilitation, as well as Medical Director of its Arts & Medicine Institute — shares perspectives on the adoption of new technologies for MS rehabilitation. The discussion touches on a range of issues, including:

  • How MS rehabilitation has evolved over the past decade
  • The importance of patient affordability when considering rehab technology options
  • The role of rhythmic music in some patients’ rehab mix
  • The potential of powered exoskeletons for MS rehabilitation
  • What’s on the horizon in MS rehabilitation

Click the player below to listen to the 19-minute podcast now, or read on below for a short edited excerpt from the portion exploring powered exoskeletons. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Dr. Bethoux: The idea with the exoskeleton is to have a robotic brace, a brace that encapsulates the legs up to the hips and pelvis, and then motors that can activate the joints of the device to help the joints of the leg move, and a complex software that responds to what sensors can catch. If the person intends to make a step, they will move their body in such a way that if the sensor catches it, then it will trigger a step assisted by the device.

It’s a way to have a machine that interacts with the person and can interact with the environment. It has safety features to prevent falling, for example, and can enhance the person’s abilities. So if the person has weakness in the legs, then the machine can do some of the walking for the person. If they become more and more tired as they walk a longer distance, the machine can take over more and more, or vice versa. If they become stronger as they walk more, then the machine will provide less assistance. For example, if with training from session to session the person becomes more adept at walking, then we can provide less and less assistance until they can do their training without the machine.

Advertisement

The idea is that the machine is really not the end of it all, and that’s really what I’ve learned through research with almost any technology. The technology is an enabler or an enhancer. It’s something that allows people to perform exercise, rehabilitation or certain functions of life in an easier way. It doesn’t replace; it just enhances. But it can enhance in such a way that it makes a meaningful difference to the person.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad